{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-001662","form_type":"8-K","ticker":"COCP","cik":"0001412486","company_name":"Cocrystal Pharma, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.110595+00:00","generated_at":"2026-06-07T02:08:38.162458+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Cocrystal Pharma provides corporate presentation; details not disclosed in filing","bullets":["Cocrystal Pharma (COCP) presented to the investment community on January 8, 2024.","Slide deck furnished as Exhibit 99.1; specific content not included in this 8-K text.","Presentation likely covers pipeline and strategy; no material new data are confirmed from filing alone."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-001662","json":"https://secwatch.observer/filing/0001493152-24-001662.json","markdown":"https://secwatch.observer/filing/0001493152-24-001662.md","text":"https://secwatch.observer/filing/0001493152-24-001662.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412486/000149315224001662/0001493152-24-001662-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412486/000149315224001662/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:08:38.162458+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}